Latest AB Science News & Updates

See the latest news and media coverage for AB Science. We track all announcements, press releases, and industry mentions in real time, all in one place.

AB Science

Biopharmaceutical company developing small molecule drugs

ab-science.com

Last updated Today

Latest news about AB Science

In short: AB Science advanced clinical data for masitinib in ALS, secured millions in private placements, and successfully renegotiated its debt repayments.

Company announcements

Yesterday AB Science

AB Science obtains US patent for masitinib in prostate cancer

The patent protects masitinib for treating metastatic castrate-resistant prostate cancer until 2042.

May 13 AB Science

AB Science reports 2025 annual financial results

The company reported its revenues for the year 2025 and provided an activity update.

April 29 AB Science

AB Science completes EUR 3.2 million private placement

The capital increase was subscribed by a limited number of investors. Announced on 29/04/2026.

April 27 AB Science

AB Science announces final agreement on loan repayment renegotiation

It includes 24-month deferral of bank debt and 12-month deferral of EIB loan.

Media coverage

Yesterday The Manila Times

AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042

This new US patent adds to the IP coverage already granted in Europe (EP4175639). Counterpart patent applications have also been filed in other major international...

June 9 Yahoo Finance

AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

PRESS RELEASE AB SCIENCE IS INVITED TO PRESENT AT THE 2026 ENCALS ANNUAL MEETING THE SURVIVAL DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS...

May 13 Markets Insider

AB Science reports its revenues for the year 2025 and provides an update on its activities

PRESS RELEASEAB SCIENCE PRESENTS ITS ANNUAL FINANCIAL RESULTS AS OF 31 DECEMBER 2025 AND KEY EVENTS FOR THE PERIODFinancial and...

April 29 Taiwan News

AB Science announces the successful completion of a EUR 3.2 million private placement

The Company intends to use the net proceeds of the Private Placement to finance its ongoing activities, with a focus on the clinical development of...

Never miss news about AB Science

Track AB Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.